Natural history of Myhre syndrome
- PMID: 35907855
- PMCID: PMC9338657
- DOI: 10.1186/s13023-022-02447-x
Natural history of Myhre syndrome
Abstract
Background: Myhre syndrome (MS) is a rare genetic disease characterized by skeletal disorders, facial features and joint limitation, caused by a gain of function mutation in SMAD4 gene. The natural history of MS remains incompletely understood.
Methods: We recruited in a longitudinal retrospective study patients with molecular confirmed MS from the French reference center for rare skeletal dysplasia. We described natural history by chaining data from medical reports, clinical data warehouse, medical imaging and photographies.
Results: We included 12 patients. The median age was 22 years old (y/o). Intrauterine and postnatal growth retardation were consistently reported. In preschool age, neurodevelopment disorders were reported in 80% of children. Specifics facial and skeletal features, thickened skin and joint limitation occured mainly in school age children. The adolescence was marked by the occurrence of pulmonary arterial hypertension (PAH) and vascular stenosis. We reported for the first time recurrent strokes from the age of 26 y/o, caused by a moyamoya syndrome in one patient. Two patients died at late adolescence and in their 20 s respectively from PAH crises and mesenteric ischemia.
Conclusion: Myhre syndrome is a progressive disease with severe multisystemic impairement and life-threathning complication requiring multidisciplinary monitoring.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Myhre and LAPS syndromes: clinical and molecular review of 32 patients.Eur J Hum Genet. 2014 Nov;22(11):1272-7. doi: 10.1038/ejhg.2013.288. Epub 2014 Jan 15. Eur J Hum Genet. 2014. PMID: 24424121 Free PMC article.
-
Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome.Am J Med Genet A. 2016 Oct;170(10):2617-31. doi: 10.1002/ajmg.a.37739. Epub 2016 Jun 14. Am J Med Genet A. 2016. PMID: 27302097 Review.
-
Natural history and life-threatening complications in Myhre syndrome and review of the literature.Eur J Pediatr. 2016 Oct;175(10):1307-15. doi: 10.1007/s00431-016-2761-3. Epub 2016 Aug 25. Eur J Pediatr. 2016. PMID: 27562837
-
The first two Chinese Myhre syndrome patients with the recurrent SMAD4 pathogenic variants: Functional consequences and clinical diversity.Clin Chim Acta. 2020 Jan;500:128-134. doi: 10.1016/j.cca.2019.10.006. Epub 2019 Oct 22. Clin Chim Acta. 2020. PMID: 31654632
-
Myhre syndrome.Clin Genet. 2014 Jun;85(6):503-13. doi: 10.1111/cge.12365. Epub 2014 Apr 2. Clin Genet. 2014. PMID: 24580733 Review.
Cited by
-
Performance and clinical utility of a new supervised machine-learning pipeline in detecting rare ciliopathy patients based on deep phenotyping from electronic health records and semantic similarity.Orphanet J Rare Dis. 2024 Feb 10;19(1):55. doi: 10.1186/s13023-024-03063-7. Orphanet J Rare Dis. 2024. PMID: 38336713 Free PMC article.
-
Objectivizing issues in the diagnosis of complex rare diseases: lessons learned from testing existing diagnosis support systems on ciliopathies.BMC Med Inform Decis Mak. 2024 May 24;24(1):134. doi: 10.1186/s12911-024-02538-8. BMC Med Inform Decis Mak. 2024. PMID: 38789985 Free PMC article.
-
Thick skin and thicker arteries: case report on a rare cause of hypertension.Pediatr Nephrol. 2025 Jul;40(7):2197-2199. doi: 10.1007/s00467-025-06691-8. Epub 2025 Jan 27. Pediatr Nephrol. 2025. PMID: 39869205
-
Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations.Eur J Hum Genet. 2024 Sep;32(9):1086-1094. doi: 10.1038/s41431-024-01664-1. Epub 2024 Jul 12. Eur J Hum Genet. 2024. PMID: 38997468
-
Psychiatric manifestations of Myhre syndrome: A case report.Indian J Psychiatry. 2023 Oct;65(10):1083-1084. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_158_23. Epub 2023 Oct 16. Indian J Psychiatry. 2023. PMID: 38108059 Free PMC article. No abstract available.
References
-
- Le Goff C, Mahaut C, Abhyankar A, Le Goff W, Serre V, Afenjar A, Destrée A, di Rocco M, Héron D, Jacquemont S, Marlin S, Simon M, Tolmie J, Verloes A, Casanova J-L, Munnich A, Cormier-Daire V. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet. 2011;44:85–88. doi: 10.1038/ng.1016. - DOI - PubMed
-
- Michot C, Le Goff C, Mahaut C, Afenjar A, Brooks AS, Campeau PM, Destree A, Di Rocco M, Donnai D, Hennekam R, Heron D, Jacquemont S, Kannu P, Lin AE, Manouvrier-Hanu S, Mansour S, Marlin S, McGowan R, Murphy H, Raas-Rothschild A, Rio M, Simon M, Stolte-Dijkstra I, Stone JR, Sznajer Y, Tolmie J, Touraine R, van den Ende J, Van der Aa N, van Essen T, Verloes A, Munnich A, Cormier-Daire V. Myhre and LAPS syndromes: clinical and molecular review of 32 patients. Eur J Hum Genet EJHG. 2014;22:1272–1277. doi: 10.1038/ejhg.2013.288. - DOI - PMC - PubMed
-
- Caputo V, Cianetti L, Niceta M, Carta C, Ciolfi A, Bocchinfuso G, Carrani E, Dentici ML, Biamino E, Belligni E, Garavelli L, Boccone L, Melis D, Andria G, Gelb BD, Stella L, Silengo M, Dallapiccola B, Tartaglia M. A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome. Am J Hum Genet. 2012;90:161–169. doi: 10.1016/j.ajhg.2011.12.011. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous